eFFECTOR Therapeutics Inc
NASDAQ:EFTR
Income Statement
Earnings Waterfall
eFFECTOR Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-33.8m
USD
|
Operating Income
|
-33.8m
USD
|
Other Expenses
|
-2m
USD
|
Net Income
|
-35.8m
USD
|
Income Statement
eFFECTOR Therapeutics Inc
Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||
Revenue |
1
N/A
|
1
-11%
|
1
+23%
|
1
N/A
|
3
+92%
|
3
+16%
|
4
+11%
|
4
+0%
|
2
-56%
|
1
-56%
|
0
N/A
|
|
Operating Income | ||||||||||||
Operating Expenses |
(25)
|
(26)
|
(33)
|
(34)
|
(38)
|
(39)
|
(36)
|
(39)
|
(37)
|
(35)
|
(34)
|
|
Selling, General & Administrative |
(5)
|
(8)
|
(13)
|
(16)
|
(17)
|
(16)
|
(13)
|
(12)
|
(12)
|
(11)
|
(11)
|
|
Research & Development |
(20)
|
(18)
|
(20)
|
(19)
|
(21)
|
(23)
|
(23)
|
(27)
|
(25)
|
(24)
|
(23)
|
|
Operating Income |
(24)
N/A
|
(25)
-6%
|
(32)
-27%
|
(33)
-3%
|
(36)
-9%
|
(36)
-2%
|
(32)
+10%
|
(35)
-9%
|
(35)
+0%
|
(34)
+4%
|
(34)
+0%
|
|
Pre-Tax Income | ||||||||||||
Interest Income Expense |
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
Non-Reccuring Items |
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
18
|
50
|
60
|
62
|
44
|
12
|
1
|
0
|
(0)
|
(0)
|
|
Pre-Tax Income |
(26)
N/A
|
(9)
+64%
|
16
N/A
|
25
+61%
|
24
-5%
|
6
-77%
|
(23)
N/A
|
(36)
-58%
|
(37)
-4%
|
(36)
+3%
|
(36)
+0%
|
|
Net Income | ||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(26)
|
(9)
|
16
|
25
|
24
|
6
|
(23)
|
(36)
|
(37)
|
(36)
|
(36)
|
|
Net Income (Common) |
(40)
N/A
|
(23)
+42%
|
16
N/A
|
25
+61%
|
24
-5%
|
6
-77%
|
(23)
N/A
|
(36)
-58%
|
(37)
-4%
|
(36)
+3%
|
(36)
+0%
|
|
EPS (Diluted) |
-0.98
N/A
|
-0.57
+42%
|
0.39
N/A
|
0.63
+62%
|
0.6
-5%
|
0.15
-75%
|
-0.55
N/A
|
-0.86
-56%
|
-0.77
+10%
|
-0.58
+25%
|
-16.37
-2 722%
|